8/9/2019 001-HIV AIDS 2015
1/54
HIV/AIDS AND THEWORKPLACE
RICARDO T. BALAGOT, MD, FPCOM
8/9/2019 001-HIV AIDS 2015
2/54
HIV AND AIDS
SESSION OBJECTIVES:
• General: To generate awareness andappreciation of the problem of IV!"I#S and itsimpact on the wor$place%
• Spe!":
& describe and e'plain IV!"I#S as an illness(
its nat)re* detection* and pre+ention(& recogni,e IV!"I#S as a wor$place iss)e(
& form)late re-entr. plans on wor$place policiesand programs on IV and "I#S%
8/9/2019 001-HIV AIDS 2015
3/54
CO#RSE O#TLINE:
I% Sit)ationer
II% Basic Information on IV and "I#S
III% /ep)blic "ct 0123 and the National4or$place 5olic.
IV% Inter+entions and /esponse
HIV AND AIDS
8/9/2019 001-HIV AIDS 2015
4/54
HIV & AIDS:The Global Pandemic
Over 15,000 men, women, and childrenare infected with HIV each day (or oneperson per second).
Half of all people who acqire HIV !ecomeinfected !efore the a"e of #5, and most die!efore the a"e of $5.
In #00%, an estimated 11.% million yon"people a"ed 15' live with HIV and I*worldwide.
8/9/2019 001-HIV AIDS 2015
5/54
+5 of people with HIV and I* live in thedevelopin" contries, sally from the poor,ethnic minority "rops, or poplations thatare socially mar"inali-ed.
orldwide, women accont for 50 ofadlts livin" with HIV.
/ore than half of those newly infected withHIV are !etween the a"es of 15 and #'years old.
HIV & AIDS:The Global Pandemic
8/9/2019 001-HIV AIDS 2015
6/54
/ore than #5 million people have died of
I* since 1+%1.
In developin" and transitional contries, +.5million are in immediate need of life savin"
I* medicines, only ' million ('#) are
receivin" the dr"s.
HIV & AIDS:The Global Pandemic
8/9/2019 001-HIV AIDS 2015
7/54
8/9/2019 001-HIV AIDS 2015
8/54
HIV & AIDS:Global Estimates, 200'
Estimate
Rane
$oth Ameica ()* million ()2 + 2)0 million
esten and -ental E!o.e 820,000 /20,000 '20 ,000
Easten E!o.e cental Asia ()1 million () + ()* million
East Asia //0,000 *30,000 ()0 million4iddle East and $oth A5ica 130,000 100,000 *0,000
-aibbean 210,000 220,000 2/0,000
So!th and So!th East Asia 1)( million )/ + 1)3 million
S!bSahaan A5ica
-ental and So!th A5ica6ceania
T6TA7
Deaths d!e to Aids
22)* million()1 million*/,000
) million()8 million
20)' + 21)2 million()2 + ()3 million*0,000 + 31,000
()1 + *) million
()3 + 2)( million
8/9/2019 001-HIV AIDS 2015
9/54
N $ % & e r ' ( C a )
e )
*orce hilippine HIV 6 I* 7e"istry
2 "eas
(0 "eas
3
"eas1"eas
( "ea
HIV & AIDS:The Phili..ine Scenaio
#o)bling Time of IV and "I#S cases
8/9/2019 001-HIV AIDS 2015
10/54
8/9/2019 001-HIV AIDS 2015
11/54
Demoa.hic Data Dec 200' an + Dec 200' -!m!lati%e Data('81 + 200'
8otal 7eported 3ases 1#4 %$5 ','#'
symptomatic 3ases 1#$ %04 $,5+#
I* 3ases $ #+ %$#/ales 1#1 2$# $,#$#9
:emales 5 10$ 1,1%19
;oth 15' yo $% #1% 2#'
3hildren
8/9/2019 001-HIV AIDS 2015
12/54
Demoa.hic Data Dec 200' an 20(0 -!m!lati%e Data('81 + 200'
8otal 7eported 3ases 1#4 1'$ ',542
symptomatic 3ases 1#$ 1'1 $,2$$
I* 3ases $ # %$'/ales 1#1 1#5 $,$529
:emales 5 1% 1,1++9
;oth 15' yo $% '2 221
3hildren
8/9/2019 001-HIV AIDS 2015
13/54
8/9/2019 001-HIV AIDS 2015
14/54
HIV & AIDS
8/9/2019 001-HIV AIDS 2015
15/54
Demoa.hic Data A!) 20(( an + A!) 20(( -!m!lati%e Data('81 + 20((
8otal 7eported 3ases 1+4 1,'14 2,'1$
symptomatic 3ases 1%+ 1,$50 4,501
I* 3ases 2 44 +$0/ales 1%# 1,$0+ 4,004
:emales 1' 102 1,'1'
;oth 15' yo 54 '1$ 1,4#2
3hildren
8/9/2019 001-HIV AIDS 2015
16/54
HIV & AIDS:The Phili..ine Scenaio
8/9/2019 001-HIV AIDS 2015
17/54
A Ac;!ied
I Imm!ne
D De5icienc"
S S"ndome
C serios and sally fatal conditionin which the !odyDs immne
system is severely weaBened and
cannot fi"ht off infection.
H H!man
I Imm!node5icienc"
V Vi!s virs which cases I*
HIV AND AIDS
8/9/2019 001-HIV AIDS 2015
18/54
CPeople with HIV DO NOT meanthey have AIDS.
C HIV remains dormant in the !ody
for several years !efore some
nBnown factors tri""er the
infections associated with I*
C/edian inc!ation period for adlt
can !e as lon" as 10 years.
Crin" this period, the people with
HIV may looB healthy and !ein"
naware of their infection stats.
HIV AND AIDS
8/9/2019 001-HIV AIDS 2015
19/54
hat is HIV in5ection<
A li5etime in5ection
$o %accine to .e%ent it
$o c!e $o sins and s"m.toms
Desto"s the imm!ne s"stem
-an be detected =ith HIVantibod" test
Vi!s does not li%e lon o!tside the bod"
8/9/2019 001-HIV AIDS 2015
20/54
hat is AIDS<
A condition =hee sins and s"m.tomsa..ea as a es!lt o5 %aio!s
o..ot!nistic in5ections7i5e theatenin
HIV ca!ses AIDS
H d ith
8/9/2019 001-HIV AIDS 2015
21/54
Ho= does a .eson =ithHIV loo> li>e<
??? @o! cant tell i5 a.eson has HIV b"meel" loo>in at
himBhe)
8/9/2019 001-HIV AIDS 2015
22/54
3' cell helps s to fi"ht a"ainst varios infections
Ho= HIV in5ects <
3'
8/9/2019 001-HIV AIDS 2015
23/54
HIV attacBs 3' cell, mltiply inside and "radally Bills them.
Once 3' are destroyed or !odyDs resistance to fi"ht infections
"oes down and person sffers from lots of infections
HIVIDs
Ho= HIV in5ects
8/9/2019 001-HIV AIDS 2015
24/54
8/9/2019 001-HIV AIDS 2015
25/54
8/9/2019 001-HIV AIDS 2015
26/54
HIV is $6T tansmitted
C thro"h casal contact in any settin"E schools, worBplace,or social settin"s.
C thro"h shaBin" hands, h""in", or a casal Biss.
C thro"h insect, food, water, clothes, toilets, swimmin"
pools, and drinBin" and eatin" tensils.
D t ti 5 HIV
8/9/2019 001-HIV AIDS 2015
27/54
Detection o5 HIVAntibod"
C 8he HIV anti!ody test
E etects HIV anti!odies in the !lood, not HIV
E nti!odies develop $&1# weeBs to 4 months
after infection
E FI=O G7IO E anti!odies cannot !e
detected in !lood, !t patient infective drin"this period
8/9/2019 001-HIV AIDS 2015
28/54
HIV antibod" Test Res!lts
POSITIVE HIV-antibody
C etection of anti!odies in the !lood indicates that infection
has occrred
C 8he person can infect others
C positive HIV&anti!ody test reslt does not mean that aperson has I*
NEGATIVE HIV-antibody
C HIV anti!odies were not detected in the personDs !loodC /ay indicate that the person is not infected O7
C 8he person may !e infected !t has not prodced detecta!le
qantities of HIV anti!odies
Pe%ention o5 HIV
8/9/2019 001-HIV AIDS 2015
29/54
Pe%ention o5 HIVIn5ection
RE4E4CER AC-DE?
A!stinence
Ce :aithfl-orrect andconsistent condomse
Do not se r"sEdcation
8/9/2019 001-HIV AIDS 2015
30/54
4edical Teatment
C 8oday there are medical treatments that
can slow down the rate at which HIV
weaBens the immne system.C 8here are other treatments that can
prevent or cre some of the illnesses
associated with I*.
Na*!'nal
8/9/2019 001-HIV AIDS 2015
31/54
G'al) '( DOLE Na*!'nal W'r+plaeG'al) '( DOLE Na*!'nal W'r+plae
P'l!P'l!
Pre-en*!'n an 'n*r'l '(
HIV/AIDS
Pr'*e*!'n '( 'r+er)0 r!12*) 3
!1n!*
Re'1n!*!'n '( !n!-!$al
re)p'n)!&!l!*
Pr'-!)!'n '( &ene"*) !n 2!124r!)+
)e**!n1)
E)*a&l!)2%en* '( Sere*ar!a*
O&5e*!-e) '( *2e ILO C'e
Pre-en* )prea '( HIV
C'%&a* )*!1%a 3
!)r!%!na*!'n M!*!1a*e *2e !%pa* '(HIV/AIDS
Pr'-!e are 3 )$pp'r*
Ra*!'nale '( RA 6789
Pre-en*!'n an 'n*r'l '( HIV/AIDS Pr'*e*!'n '( r!12*) an !1n!* '( PLWHA
Re'1n!*!'n '( r'le '( PLWHA !n pre-en*!'n an'n*r'l
Pr'-!)!'n '( 'n*r'l %ea)$re) !n 2!124r!)+)e**!n1)
Na*!'nalRe)p'n)e
8/9/2019 001-HIV AIDS 2015
32/54
The Phili..ine HIV
and AIDS Pe%entionand -ontol Act o5
(''8
REP#C7I- A-T 8*01
/" 0123 enacted on 6ebr)ar.78* 7990I// was prom)lgated on "pril
78* 7999
8/9/2019 001-HIV AIDS 2015
33/54
roml"ates policies and prescri!es measres
Instittes a nationwide HIV and I* information
and edcation pro"ram Gsta!lishes a comprehensive HIV and I*
monitorin" system
*tren"thens the hilippine =ational I*
3oncil
REP#C7I- A-T 8*01
8/9/2019 001-HIV AIDS 2015
34/54
Pr'-!)!'n) Rele-an* *' *2eW'r+plae
Ar*!le I : E$a*!'n an In('r%a*!'n
"rticle II : Safe 5ractices and 5roced)res
Ar*!le III : Te)*!n1, Sreen!n1 3
C'$n)el!n1
"rticle IV : ealth and S)pport Ser+ices
"rticle V : onitoringAr*!le VI : C'n"en*!al!*
Ar*!le VII : D!)r!%!na*'r A*) an
p'l!!e)
"rticle VIII : The 5hilippine National "I#S
REP#C7I- A-T 8*01
8/9/2019 001-HIV AIDS 2015
35/54
(Section 6. HIV/AIDS In('r%a*!'n !n *2e W'r+plae Ar*!le I. ED#CATION 3Ar*!le I. ED#CATION 3INFORMATIONINFORMATION
All 1'-ern%en* an pr!-a*e e%pl'ee) )2all &epr'-!e !*2 )*anar!;e &a)! !n('r%a*!'n an!n)*r$*!'n 'n HIV/AIDS< S2all &e !n*e1ra*e !n*' 'r!en*a*!'n, *ra!n!n1,'n*!n$!n1 e$a*!'n, HR e-0* pr'1ra%), e*.
Ea2 e%pl'er )2all e-el'p, !%ple%en*, e-al$a*e an($n a 'r+plae HIV/AIDS e$a*!'n an !n('r%a*!'npr'1ra%.
In 'lla&'ra*!'n !*2 *2e DOH, DOLE )2all '-er)ee *2e
an*!4HIV/AIDS a%pa!1n !n all pr!-a*e '%pan!e)<
REP#C7I- A-T 8*01
8/9/2019 001-HIV AIDS 2015
36/54
8/9/2019 001-HIV AIDS 2015
37/54
All 2eal*2 pr'(e))!'nal), %e!al!n)*r$*'r), 'r+er), e%pl'er),rer$!*%en* a1en!e), !n)$rane '%pan!e),a*a en'er), an '*2er $)*'!an) '( an
%e!al re'r) / *e)* re)$l*) *' '&)er-e)*r!* 'n"en*!al!* par*!$larl *2e!en*!* an )*a*$) '( per)'n) !*2 HIV.
Ar*!le VI:CONFIDENTIALIT= Section 0) 4edical -on5identialit"Section 0) 4edical -on5identialit"
REP#C7I- A-T 8*01
8/9/2019 001-HIV AIDS 2015
38/54
D!)r!%!na*!'n !n an ('r% (r'% pre4*' p')*4e%pl'%en*, !nl$!n1 2!r!n1,pr'%'*!'n 'r a))!1n%en*, &a)e 'n *2ea*$al, pere!-e 'r)$)pe*e HIV )*a*$) '( an !n!-!$al !)
pr'2!&!*e.
Ter%!na*!'n (r'% 'r+ 'n *2e )'le&a)!) '( a*$al, pere!-e 'r )$)pe*eHIV )*a*$) !) ee%e $nla($l%
Ar*!le VII. DISCRIMINATION ACTS 3POLICIESSection *) Discimination in the o>.laceSection *) Discimination in the o>.lace
REP#C7I- A-T 8*01
8/9/2019 001-HIV AIDS 2015
39/54
HIVBAIDS and the
o>.lace
8/9/2019 001-HIV AIDS 2015
40/54
h" C!siness Sho!ld -ae
It is mandated !y law
It will contri!te to the attainment of the /
It is "ood for the contry
It impacts !siness
8/9/2019 001-HIV AIDS 2015
41/54
C *ti"ma and iscriminationC 8ension amon" worBers
C ender ineqalities
C ressre on health 6 social secrity systems
C 8hreatened occpational safety and health!enefits of worBers
Im.act in the o>.lace
8/9/2019 001-HIV AIDS 2015
42/54
ReducedProductivity
(assume 50%)/yr
Care &
Maintenance/yr
Exit Costs (OneTime)
Medical
Redundancy
or
Death
+
Lost Training
+
Recruitment
TOTAL
Sr. Leadersi!
Mana"eria#
&Su!ervisory
$ 4!000
$ "0!000
#40!000
50!000
0!000
"0!000
$ %'*'+'''
Su!!ort Sta,,
$ "!000
$ "0!000
5!000
5"!000
!000
4!000
$ -+'''
$ &!000
$ "0!000
"4!000
#!000
#!000
"!000
$ 00+'''
R!nnin -osto5 Poamme:
*0 Bem.lo"eeB"
Vs)
The Business Case for
an HIV and AIDS in the
Workplace Program
(ased on the
Shell e!perience"
Im.act in the o>.lace
4hat can be done in the
8/9/2019 001-HIV AIDS 2015
43/54
4hat can be done in thewor$places;
The wor$place can help
limit the spreadand alle+iate the
impact of IV and "I#S%
Enterprises can respond to the
8/9/2019 001-HIV AIDS 2015
44/54
7% Thro)gh polic. de+elopment g)ided b.e'isting labor laws and standards
/" 0123 and the National4or$place 5olic.
8/9/2019 001-HIV AIDS 2015
45/54
hat com.anies need to do
C 3reate company policy on HIV and
I* prevention
C olicy to !e disseminated to all
worBers
8/9/2019 001-HIV AIDS 2015
46/54
C rovide information and edcation, trainin" if
needed
E what is HIV and I* E what are the effects of HIV and I* to the person
as a worBer, to the company, to the commnity
E how it can !e prevented
E what are the availa!le services&within
and otside of the company
hat com.anies need to do
8/9/2019 001-HIV AIDS 2015
47/54
8/9/2019 001-HIV AIDS 2015
48/54
?I8* & OJG
C -om.anies =ith HIV and AIDSPolic" and Poams
3,38
B)rea) of >abor Statistics & Integrated S)r+e.Non "gric)lt)ral Establishments Emplo.ing
8/9/2019 001-HIV AIDS 2015
49/54
1 1W'r+plae In*er-en*!'n) 'n
HIV an AIDS Pre-en*!'n
• W2a* '%pan!e) are '!n1& information and ed)cation
?participants became IV and "I#Sed)cators@
& Nondiscriminator. polic. statements
& Integration of IV polic. in their OS polic.and program
& Corporate social responsibilit. acti+ities
D'$%en*!n1 Pr'1ra%):
8/9/2019 001-HIV AIDS 2015
50/54
C'%pan!e) rep'r*e *2e ('ll'!n1pr'&le%) !n *2e!r p'l! an pr'1ra%
!%ple%en*a*!'n:
• >ac$ of management and wor$er s)pport
• >ac$ of technical capabilit. to implementtheir policies and programs
• 6ocal persons ha+e other f)nctions• STI* IV and "I#S disc)ssions not well
accepted b. both management and wor$ers
1 1W'r+plae In*er-en*!'n) 'n
HIV an AIDS Pre-en*!'n
8/9/2019 001-HIV AIDS 2015
51/54
P'l! S*a*e%en*
Re)pe* *2e !n!-!$al r!12*) an!1n!* '( pe'ple !*2 HIV an AIDS
Pr'%'*e n'n4!)r!%!na*'re%pl'%en* re1arle)) '( HIV )*a*$),
1ener, )e@$al 'r!en*a*!'n En'$ra1e %a@!%$% par*!!pa*!'n '(
!*) e%pl'ee) !n HIV an AIDSe$a*!'n pr'1ra%
Sa%ple W'r+plae P'l! '( a P2!l!pp!ne C'%pan
Sa%ple W'r+plae P'l! '( a P2!l!pp!ne C'%pan
8/9/2019 001-HIV AIDS 2015
52/54
P'l! )*a*e%en* 'n 'n*!n$e e%pl'%en*
“In order to manage employees’ HIV status moreeffectively, the company aims to assist employeeswho are HIV positive to remain well for as long as
possile. !mployees, however, need to ma"e a choiceas to whether they wish to carry on in the sameposition or accept a position which is less stressful.#his would e dependent on availaility of alternativepositions$.
“%hen an employees’ performance decreases, they wille treated e&uitaly and in a non'discriminatorymanner, resolving issues of sic" leave, pensionenefits and medical aid as for other employees witha life threatening disease$.
Sa%ple W'r+plae P'l! '( a P2!l!pp!ne C'%pan
THE WA=
8/9/2019 001-HIV AIDS 2015
53/54
THE WA=FORWARD
C /=G/G=8 and O7KG7* shall @ointlydevelop HIV and I* policies to !e translatedinto pro"rams made Bnown to all worBers.
C ctions shold focs on how to stren"thenpreventive measres despite e>istin" limitations.
8/9/2019 001-HIV AIDS 2015
54/54
THA$J @6#)
Top Related